ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 1,258 | 3,781 | 493 | 14,439 | 258 |
| Gross Profit | 1,258 | 3,781 | 493 | 14,439 | 258 |
| Operating Expenses | 48,684 | 21,795 | 9,173 | 12,076 | 10,311 |
| Operating Income | -47,426 | -18,014 | -8,679 | 2,363 | -10,052 |
| Interest Expense | 147 | 0 | 0 | 0 | 0 |
| Other Income | 45 | 588 | 1,095 | 428 | 401 |
| Pre-tax Income | -47,528 | -17,425 | -7,584 | 2,791 | -9,651 |
| Net Income Continuous | -47,528 | -17,425 | -7,584 | 2,791 | -9,651 |
| Net Income | $-47,528 | $-17,425 | $-7,584 | $2,791 | $-9,651 |
| EPS Basic Total Ops | -50.38 | -23.03 | -10.80 | 4.68 | -17.99 |
| EPS Basic Continuous Ops | -50.38 | -22.96 | -10.71 | 4.74 | -17.91 |
| EPS Diluted Total Ops | -50.38 | -23.03 | -10.80 | 4.68 | -17.99 |
| EPS Diluted Continuous Ops | -50.38 | -22.96 | -10.71 | 4.68 | -17.91 |
| EBITDA(a) | $-47,288 | $-17,971 | $-8,590 | $2,481 | $-9,951 |